| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |